A stochastic SIR epidemic dynamic model with distributed-time-delay, for a two-scale dynamic population is derived. The distributed time delay is the varying naturally acquired immunity period of the removal class of individuals who have recovered from the infection, and have acquired natural immunity to the disease. We investigate the stochastic asymptotic stability of the disease free equilibrium of the epidemic dynamic model, and verify the impact on the eradication of the disease.
Introduction
The recent advent of high technology in the area of communication, transportation and basic services, multilateral interactions have afforded efficient global mass flow of human beings, animals, goods, equipments and ideas on the earth's multi-patches surface. As a result of this, the world has become like a neighborhood. Furthermore, the national and binational problems have become the multinational problems. This has generated a sense of cooperation and understanding about the basic needs of human species in the global community. In short, the idea of globalization is spreading in almost all aspects of the human species on the surface of earth. The world today faces the challenge of increasingly high rates of globalization of new human infectious diseases and disease strains [1] associated with the high number of inter-patch connections modern efficient global human transportation. For instance, the recent 2009 H1N1 flu pandemic [2] is closely interrelated with the many inter-patch connections facilitated human transportation of the disease. Attempts to study human infectious disease dynamics influenced by human mobility process in complex human meta-population structures are made [3] - [15] .
The inclusion of the effects of disease latency or immunity into the epidemic dynamic modeling process leads to more realistic epidemic dynamic models.
Furthermore, epidemic dynamic processes in populations exhibiting varying time disease latency or immunity delay periods are represented by differential equation models with distributed time delays. Several studies [16] [17] [18] [19] [20] incorporating distributed delays describing the effects of disease latency or immunity in the dynamics of human infectious diseases have been done. A mathematical SIR (susceptible-infective-removal) epidemic dynamic model with distributed time delays representing the varying time temporal immunity period in the immune population class is studied by Blyuss and Kyrychko [19] . In their study, the existence of positive solution is exhibited. Furthermore, the global asymptotic stability of the disease free and endemic equilibria are shown by using Lyapunov functional technique. Moreover, they presented numerical simulation results for a special case SIR epidemic with temporal immunity. The temporal immunity was represented in the epidemic dynamic model by letting the Dirac delta-function be the integral kernel or the probability density function of the distributed time delay.
Stochastic models also offer a better representation of the reality. Several stochastic dynamic models describing single and multi-group disease dynamics have been investigated [20] - [29] . In [21] , a stochastic multi-group SIRS epidemic dynamic models is derived and studied. The random environmental fluctuations manifest as variability in the disease transmission process. In addition, the global positive solution existence is exhibited by the Lyapunov energy function method and a positively self invariant set is defined. Moreover, the the stochastic asymptotic and mean square stability of the disease free equilibrium are exhibited by applying Lyapunov second method. In [22] , D. Wanduku and G.S. Ladde derived and studied a stochastic two-scale network constant temporary delayed SIR epidemic model. The temporary immunity period accounts for the time lag during which newly recovered individuals from the disease with conferred infection acquired or natural immunity lose the immunity and regain the susceptible state. They utilized the Lyapunov energy function method to prove the global positive solution process existence, and defined a positively self invariant set. Moreover, the the stochastic asymptotic and mean square stability of the disease free equilibrium are exhibited by applying Lyapunov functional technique. In [20] , a stochastic SIR epidemic dynamic model with distributed time delay is studied. Moreover, the stochastic asymptotic stability of the disease free equilibrium is also exhibited by applying the Lyapunov functional techni-que.
In this paper we extend the two-scale network SIR temporary delayed epidemic dynamic model [22] into a two-scale network SIR delayed epidemic dynamic model with varying natural immunity period. The varying immunity period accounts for the varying time lengths of immunity within the immune population class. This means that individuals recovering from the disease acquire natural immunity against the disease. Moreover, the immunity period varies for individuals in the immune population class. Furthermore, the acquired immunity wanes with time and the temporary immune individuals are reconverted to the susceptible state.
This work is organized as follows. In Section 2, we derive the distributed time acquired immunity delay epidemic dynamic model. In Section 3, we present the model validation results of the epidemic model. In Section 4, we show the stochastic asymptotic stability of the disease free equilibrium.
Derivation of the SIR Distributed Delay Stochastic Dynamic Model
In this section, we derive the varying immunity delay effect in the SIR disease dynamics of residents of site 
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where all parameters are previously defined. Furthermore, for each ( ) be an arbitrary vector defined in (2.6) , where ( )
, ,
 is defined as follows 
Model Validation Results
In the following we state and prove a positive solution process existence theorem for the delayed system (2.1)-(2.3). We utilize the Lyapunov energy function method in our earlier study [22] 
and we show that 
We rewrite (3.2) as follows
And (3.3) further implies that
where dV is the Ito-Doob differential operator with respect to the system (2.1)-(2.3). We express the terms on the right-hand-side of (3.4) in the following:
Site Level: From (3.2) the terms on the right-hand-side of (3.4) for the case of 
Regional Level: From (3.2) the terms on the right-hand-side of (3.4) for the 
It follows from (3.5)-(3.7), (3.4), and (3.1) that for 
Suppose on the contrary that ( ) 0
In the same structure form as (3.2) and (3.4), define ( 
Regional Level: From (3.11), the terms of the right-hand-side of (3. Finally, by the total probability principle, s present at home site and also visiting sites in regions in their intra and inter-regional accessible domains [21] , given by the sum
, is nonnegative. Moreover, the total effective population [21] , defined by ( )( ) .3) that is under the influence of human mobility process [30] 
is a positive self-invariant set for system (2.1)-(2.3). We shall denote 
Existence and Asymptotic Behavior of Disease Free Equilibrium
In this section, we study the existence and the asymptotic behavior of the disease free equilibrium state of the system (2. 
The asymptotic stability property of , first, we use the change of variable that shifts the equilibrium to the origin. For this purpose, we use the following transformation: 
We state and prove the following lemmas that would be useful in the proofs of the stability results. 
Proof: See ( [22] , Lemma 4.1).
Remark 4.1. Lemma 4.1 shows that the Lyapunov function V defined in (4.7) is positive definite, decrescent and radially unbounded (4.8) function [31] [32] .
We now state the following lemma. 
where, human mobility patterns will appear elsewhere.
We note that the disease dynamics is subject to random environmental perturbations from other related sub-processes such as the mobility, recovery, birth and death processes. The variability due to the disease transmission incorporated in the epidemic dynamic model will be extended to the variability in the mobility, recovery and birth and death processes. A further detailed study of the oscillation of the epidemic process about the ideal endemic equilibrium of the dynamic epidemic model will also appear else where. In addition, a detailed study of the hereditary features of the infectious agent such as the time-lag to infectiousness of exposed individuals in the population is currently underway and it will also appear elsewhere.
